Top Biopharmaceutical Experts 2025

Emanuele Andreano is an immunologist and biotech innovator redefining how vaccines are discovered for pandemic threats. As Head of Serology and Immunology at the Fondazione Biotecnopolo di Siena and a leader in the European Vaccine Hub, he works at the intersection of AI, immunology, and global health. He pioneered Reverse Vaccinology 3.0, a breakthrough approach that can identify entirely new vaccine targets in days instead of years. In a first-of-its-kind demonstration, his team showed that artificial intelligence can predict unknown viral antigens directly from human antibody sequences—effectively reversing the traditional vaccine discovery process. His work spans monoclonal antibody discovery and next-generation vaccines against emerging pathogens, including mpox and SARS-CoV-2, with direct implications for global pandemic preparedness and biosecurity. Andreano has received international recognition, including the Antonio Feltrinelli Prize from the Accademia Nazionale dei Lincei, awarded in the presence of the President of the Italian Republic Sergio Mattarella, the IUIS Rising Star in Immunology, and a European Research Council (ERC) grant. He also co-directs a vaccinology program at the Institut Pasteur in Paris. “We are entering an era where vaccines can be discovered at unprecedented speed—transforming our ability to fight pandemics and save countless lives.”

AI meets biotech — straight from Zug, Switzerland Get the latest AI news, learn must-know AI tools, and keep up with Biotech news in just 5 minutes a week. Join our readers growing their careers with the AIxBiotech newsletter. Founded by executives who have led global biotech and tech teams, AIxBiotech is on a mission to make AI practical for themodern biotech office. In just a few months, we’ve attracted a fast-growing audience of biotech professionals and innovation leaders — from early-stage founders to Fortune 500 executives. Our readers span Europe and North America, with a strong base in the U.S. and Switzerland. We’re building organically, one engaged reader at a time — with the ambition to reach 500K professionals within our first year.

I am a practicing clinical pharmacist with over 20 years of experience and a graduate of St. John’s University School of Pharmacy in Queens, NY. With an undergraduate background in compounding and natural medicine, I have served in various capacities across the pharmaceutical industry before founding Fusion Medical Care in Scottsdale, AZ. My career is defined by my dedication to a balanced approach between natural and allopathic medicine, a passion that led me to develop a complete wellness center housing multiple integrative practitioners. Beyond my foundational education, I have advanced my specialized training through the Professional Compounding Centers of America and am a Certified Diplomate of the American Board of Anti-Aging Health Practitioners. I believe that my role as a pharmacist offers the perfect opportunity to fuse naturopathic and allopathic care, acting as a dedicated advocate for my patients' pharmacological and wellness needs. My mission is to empower patients to look and feel amazing by following my core philosophy: "Let your food be your medicine, your kitchen be your pharmacy, and your lifestyle be your doctor". My innovative approach to healthcare has earned me national recognition, including an honor in Marquis Who’s Who and a featured interview with VoyagePhoenix highlighting my journey and the mission behind Fusion Medical Care.

Ryan Farmer is the founder of My Peptide Match, a consumer education site that helps people make sense of GLP-1 medications and the fast-changing peptide landscape. He focuses on simplifying complex topics—like real-world pricing, treatment pathways, sourcing differences, and what questions to ask—so readers can make more informed decisions with their clinician. Ryan tracks emerging trends across weight-loss peptides, compounding and telehealth access, and the economics that shape what consumers actually pay. He’s available to comment on GLP-1 and peptide cost comparisons, patient decision-making, and the broader market shifts driving demand. He also publishes practical reference tools, including a peptide calculator and dosage guide, to support clearer conversations between consumers and providers.

Dr. Akshaya Srikanth Bhagavathula is an Associate Professor of Epidemiology at North Dakota State University, internationally recognized for his pioneering work at the intersection of digital epidemiology, pharmacovigilance, and artificial intelligence. His research harnesses advanced statistical modeling and AI to track and predict health behaviors, medication safety, and disease patterns in real time—bridging traditional epidemiology with next-generation digital health analytics. Dr. Bhagavathula has published more than 250 peer-reviewed articles in leading journals, including Annals of Epidemiology, JAMA Network Open, and Lancet Digital Health. His work has been widely cited and featured in major media outlets such as The New York Times, where he discussed the real-world safety of GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy, Mounjaro). Recognized among the Stanford–Elsevier Top 2% of Scientists (2019–2024) and elected as a Fellow of the American College of Epidemiology, Dr. Bhagavathula is known for translating complex data into actionable insights that shape public health policy and clinical practice. His ongoing projects include NIH- and NSF-aligned initiatives on AI-powered overdose forecasting, digital twins for public health, and real-world drug safety surveillance using explainable machine learning. With a decade of experience spanning more than two dozen countries and collaborations with organizations such as WHO, USAID, and UNICEF, Dr. Bhagavathula brings a global, data-driven, and human-centered approach to solving modern health crises.

Dr. Robert Abraham is a regenerative medicine consultant and healthcare strategy advisor with more than a decade of experience operating multi-location healthcare practices. He earned his Bachelor of Science in Health Sciences and Biology from the University of Central Florida before pursuing advanced training in clinical operations and regenerative-focused program development. Based in Florida, Dr. Abraham has worked with healthcare organizations throughout the Orlando region and nationwide, advising clinics on structured implementation, operational systems design, revenue forecasting, and compliance-conscious growth within regenerative medicine and wound care services. In addition to his consulting work, he serves as Chief Executive Officer of Cross Biotech, a biologics distribution company supporting providers in aligning product access with disciplined operational frameworks. His work emphasizes infrastructure-driven expansion, leadership accountability, and sustainable healthcare systems.

Shane Hellmrich holds a BSc in Health Promotion and has spent the past 11 years independently testing and reviewing online modafinil vendors — placing personal test orders, verifying product authenticity, and documenting shipping reliability across dozens of suppliers. His work at BuyModa.net tracks over 1,300 verified customer transactions and maintains a public testing methodology that has become a trusted reference point for consumers navigating the grey-market pharmaceutical space. Shane's research covers vendor reliability scoring, product authentication, shipping logistics across international jurisdictions, and the pharmacokinetic profiles of generic modafinil products. He is regularly consulted on topics including nootropics and cognitive enhancement, online pharmacy safety and regulation, pharmaceutical sourcing and supply chain transparency, consumer protection in unregulated markets, and the real-world usage patterns of prescription cognitive enhancers. Shane is available for expert commentary, background briefings, and on-the-record quotes for journalists covering health, productivity, pharmacology, biohacking, and consumer safety.

Clinical trial management of two stem cell clinical trials. I have a passion for data science analytics and rigorous pattern-seeking. I believe in leading from the front and making sure the team is well taken care of. *Managing 2 stem cell clinical trials, NCT02838316 and NCT05421689*30 peer-reviewed publications.*>12,000 citations.*2 provisional patents.*Co-founded startup.*Co-developed departmental leadership program.*Strong track record of grant funding and collaboration building.* Associated Editor for two flagship scientific journals (Stem Cells, Journal of Extracellular Biology).GOOGLE SCHOLAR PROFILEhttps://scholar.google.com/citations?user=3uQtjEEAAAAJ&hl=en

Tomo Marjanovic is the Founder and CEO of Aspire Rejuvenation Clinic, a multi-million dollar hormone optimization and regenerative medicine company with clinics in four U.S. cities and expansion underway in Cleveland and Dubai. Named a Top 100 Healthcare Visionary by IFAH, Marjanovic has treated thousands of patients through bioidentical HRT, peptide therapy, stem cell and exosome treatments, and medical weight loss programs. Before building Aspire, Marjanovic spent 12 years in law enforcement in Ohio and Florida, earning the Public Safety Medal of Valor. After chronic night shift work destroyed his hormonal health and the medical system failed to help, he got certified in Advanced Bioidentical Hormone Replacement Therapy through Worldlink Medical and built the company he wished existed when he was the patient. Marjanovic is the author of "Operation Optimal: Health, Wellness, & Becoming Your Best You" and host of the Tomo Talks podcast. He holds a BA in Criminal Justice Administration (Cum Laude) from Tiffin University and is a former competitive bodybuilder. His work has been featured in USA Today, NY Post, Miami Herald, Modern Luxury, and Authority Magazine. He is available to speak on hormone optimization, testosterone therapy, longevity medicine, regenerative therapies, peptides, men's health, stress and cortisol, health entrepreneurship, veteran and first responder wellness, the GLP-1 market, healthcare franchising, and the intersection of health and wealth.

Dr. Giovanni Abbadessa is a seasoned oncology developer with over 20 years of experience in advancing innovative therapies across biotech, pharmaceutical, and nonprofit sectors. He joined ModeX Therapeutics as Chief Medical Officer, where he leads the development of the company’s multispecific biologics for cancer and infectious diseases. Prior to ModeX, Dr. Abbadessa was Vice President and Head of Oncology Early Development at Sanofi, where he spearheaded the clinical development of 16 experimental oncology drugs, guiding them from first-in-human studies through to Phase 2 trials. He established a dynamic team of 25 professionals and played a pivotal role in in-licensing 10 clinical assets. Dr. Abbadessa contributed to strategic oversight across multiple portfolios, including Phase 3 assets and partnerships, and collaborated with Investor Relations on oncology-focused initiatives.

I am the Chief Medical Officer at Boomerang Health Care, a state of the art multidisciplinary specialty group offering interventional, surgical and rehabilitative care through its 25 clinics in California. I also serve as the Medical Director at Le Reve: Regen, a leader in cutting edge restorative and regenerative solutions for Spine, Orthopedics and Musculoskeletal conditions. In the academic world, I have served as a Clinical Faculty at Stanford University for more than 20 years and have established myself as a world leader in cutting edge innovative therapeutic solutions. I completed her Anesthesiology residency from Medical College of Wisconsin, Milwaukee and Fellowship in Pain Medicine from the University of California, Davis. I am board certified in Anesthesiology and Pain Medicine by American Board of Anesthesiology, in Interventional Pain by American Board of Interventional Pain Physicians and in Regenerative Medicine by American Board of Regenerative Medicine. I sit on the Editorial board of the journal, Pain Physician and serve on the board of the American Society of Interventional Pain Physicians, Latin American Pain Society, California Society of Industrial Medicine and Surgery, California Society of Interventional Pain Physicians and Scilex (Nasdaq: SCLX). I am humbled to receive the Distinguished Service Award, Outstanding Achievement Awards and other accolades. I have devoted my entire career to the field of Interventional spine and Regenerative medicine and have contributed via several peer reviewed journal articles, visionary editorials, and book chapters. My book, “Essentials of Regenerative Medicine” is first in its right illustrating latest interventional biologic techniques for spine and musculoskeletal injuries. I have also authored several National Guidelines including the ones on Opioids, Interventional Spine Epidural procedures, Facet joints, and the first ever on the Safe and Effective use of Biologics in Lumbar spine. I have completed the first prospective, multicenter, randomized placebo controlled trial demonstrating efficacy of platelet rich plasma and bone marrow concentrate in patients with back pain related to disc injury/degeneration. I consider myself an authority on global health care trends including digital health, technology innovations and applied biologics. Let’s connect and work together to make healthcare better, faster, and more effective – www.annunavani.com.

I am an MD-PhD physician-scientist with a passion for translating complex clinical and scientific data into clear, accurate content. My training and experience span clinical practice and translational research, with expertise across oncology, immunology, gastroenterology, inflammation & metabolism, and rare diseases. With over 10 years of experience, I have supported key deliverables including more than 30 peer-reviewed publications, manuscripts, slide decks, literature reviews, and scientific narratives. I enjoy working in collaborative, deadline-driven environments and am particularly interested in medical writing, medical information, and publication development, where scientific accuracy and effective storytelling intersect.

*Board-Certified Family Medicine Physician (ABFM) with 14+ years clinical experience (based in Chicago, IL) *Named Castle Connolly Top Doctor (2024, 2025) *Medical Media Commentator seen on/in ABC 7, Fox 32, CBS 2, WGN 9, The Chicago Tribune , Chicago Sun Times, and Everyday Health; including a nationwide 25 interview satellite media tour (TV & radio, November 2025) *Premedical Student Mentor, Urban Bridges Medical Mentoring Program Dr. Rene is a board-certified Family Medicine physician and Fellow of the American Academy of Family Physicians (FAAFP) with 14+ years of clinical experience. She provides comprehensive primary care for Medicare-eligible patients at Oak Street Health's Avalon Park location in Chicago, specializing in chronic disease management, preventive care, healthcare equity, and access for underserved communities. After overcoming 50 medical school rejections, Dr. Rene graduated from Indiana University School of Medicine and completed residency training at Ascension Saint Joseph Hospital - Chicago. She developed the L.Y.M.I.T.S. Method—a framework for transforming limitations into your greatest strengths. She mentors aspiring physicians through the Urban Bridges Medical Mentoring Program. Dr. Rene has appeared as a medical expert on ABC 7, Fox 32, CBS 2, and WGN 9 Chicago and recently completed a 25-interview national satellite media tour. She is available for expert commentary on resilience in healthcare, medical education equity, resilience and overcoming failure, healthcare access for underserved populations, and diversity in medicine.

Pharma Clinical Formulator and Founder of EARTHLYF Clinical Skincare. Expert in the Indian exposome, barrier repair chemistry, INCI transparency, and building a D2C startup in the personal care industry.

Dr. Shiv Goel, MD is a board-certified physician and the founder of Prime Vitality Care, a physician-led functional medicine and wellness clinic based in San Antonio, Texas, with telehealth services available to patients in all 50 states. Dr. Goel trained in internal medicine and functional and integrative medicine, and has spent his career building a practice model that treats the root causes of poor health rather than managing symptoms in isolation. His clinical philosophy is grounded in the understanding that hormones, metabolism, inflammation, gut health, and mental well-being are deeply interconnected systems — and that lasting health improvements require addressing all of them together. Prime Vitality Care specializes in physician-supervised GLP-1 medical weight loss programs using semaglutide and tirzepatide, bioidentical hormone replacement therapy (BHRT) for women, testosterone replacement therapy (TRT) for men, peptide therapy including Sermorelin, BPC-157, and PT-141, and comprehensive functional medicine consultations for patients with chronic fatigue, gut dysfunction, autoimmune concerns, and metabolic disease. Dr. Goel is a sought-after expert on the clinical application of GLP-1 therapies, the role of hormonal imbalance in weight resistance, and the future of physician-led telehealth medicine. He speaks regularly to the gap between what conventional medicine offers patients with metabolic dysfunction and what a root-cause, functional approach can deliver when the right diagnostics and time are applied. Through Prime Vitality Care's HIPAA-compliant telehealth platform, Dr. Goel brings the same standard of clinical depth and personalization to patients nationwide that San Antonio patients have relied on in person — with lab coordination through local Quest Diagnostics or CPL sites and all prescriptions compounded and shipped directly to patients.

Dr. Boluwatife OLU Afolabi is a dental surgeon and PhD candidate in Oral Biology at the University of Minnesota School of Dentistry. His research focuses on the molecular mechanisms driving head and neck squamous cell carcinoma, particularly the role of environmental carcinogens, inflammatory signaling, and transcriptional regulation in disease initiation and progression. His work investigates pathways such as the Aryl Hydrocarbon Receptor (AHR) and S100A8/S100A9-mediated inflammatory responses using cellular and molecular models of oral epithelial transformation. He has extensive experience in cancer biology, oral pathology, toxicology, and translational biomedical research. Dr. Afolabi provides expert insight on oral cancer risk factors, environmental exposures and health, inflammation and disease mechanisms, dental-systemic health connections, and emerging directions in cancer research. He is also interested in public health implications of carcinogen exposure and prevention strategies in oral and head-and-neck disease.

Dr. Frank D. Yelian, MD, PhD, is the Founder and Director of Life IVF Center, one of the West Coast's largest independent fertility practices. At Life IVF, he leads a highly specialized fertility program focused on delivering results in the most challenging cases. With dual training as a physician and scientist, Dr. Yelian combines rigorous clinical expertise with a deep understanding of reproductive biology to develop highly individualized treatment strategies. Dr. Yelian is widely recognized for his work with patients who have experienced prior IVF failure, particularly those with diminished ovarian reserve (DOR), advanced maternal age, and other complex diagnoses. His clinical approach centers on Precision IVF® protocols, which emphasize careful calibration of medication dosing to align with each patient’s unique physiology. This method is designed to maximize treatment effectiveness while reducing unnecessary medication costs and limiting exposure to potentially harmful side effects. At Life IVF Center, Dr. Yelian has built a reputation for treating patients that many clinics decline. His program consistently achieves successful outcomes in cases considered low probability, supported by advanced diagnostics, refined stimulation strategies, and a high-performance embryology laboratory. In addition to his work with complex IVF cases, Dr. Yelian has extensive experience in travel IVF, egg donation, and gestational surrogacy, providing comprehensive solutions for both domestic and international patients. His ability to manage intricate clinical scenarios across these pathways has made Life IVF Center a destination for patients seeking expertise beyond standard fertility care. Dr. Yelian’s work is defined by a commitment to precision, innovation, and results, establishing Life IVF Center as a leader in advanced reproductive medicine for patients who require a more sophisticated and individualized approach.

In my role, I meticulously oversee various clinical projects, ensuring each phase is executed with precision and in compliance with GCP standards. Core Competencies: Clinical Trials Monitoring Clinical Safety Protocols Streamlined Clinical Operations Regulatory Compliance Mastery Educational Background: MSc in Molecular Science and Nanotechnology, Louisiana Tech University MSc in Medical Genetics, MGM University of Health Sciences With a robust educational foundation and a keen eye for detail, I have successfully navigated through different therapeutic areas and regions, delivering high-quality results consistently. My journey in the realm of clinical research is driven by an insatiable curiosity and a deep-seated commitment to advancing science and practice. Let’s Connect! If you are passionate about transforming health care and improving patient lives, or if you wish to exchange insights and collaborate on projects, feel free to connect with me. Together, let’s contribute to a healthier, more understanding world for individuals navigating through challenges.

With a PhD in molecular genetics and as a specialist in data science, Céline Chantry-Darmon has over twenty years of experience in biomedical research and complex data analysis. As Scientific Director at Tekkare, she works on developing trustworthy artificial intelligence for healthcare. She is also committed to promoting inclusive and responsible artificial intelligence, and to advancing women in science and technology.

Dr. James Utley is a pioneering scientist at the forefront of cellular therapy, AI, and data science. A Johns Hopkins-educated Immunohematology expert and Certified Advanced Biotherapies Professional (CABP), he also holds advanced certifications in data science and machine learning. While serving as Technical Director at a major healthcare organization, Dr. Utley oversaw more than 150,000 successful cellular transfusions and spearheaded advancements that significantly improved patient outcomes. This experience included leading initiatives for the Department of Defense, where he revolutionized cellular transfusion practices. His innovative approach is further exemplified by his FDA-approved work and numerous publications in leading scientific journals. Dr. Utley is also known for his bold, hands-on approach to research, embodying the spirit of a "biohacker" by pushing the boundaries of CRISPR and genetic engineering through self-experimentation. This unique blend of rigorous scientific training and unconventional methods has earned him the moniker "the pirate" within the biohacker community.